Industry Focus

It’s Halloween and we’ve got a special show for you. Motley Fool Contributor Dan Kline joins the show and we break down our biggest fears in the market today, list out the stocks we think are going to turn into pumpkins, shared our zombie stocks that are set to come back from the dead, and then Dan, Nick, and Austin share their Mt. Rushmore of Halloween Candy.

Direct download: 20191031_IF_Energy.mp3
Category:Podcast -- posted at: 4:21pm EST

Biogen's drug pipeline took a massive hit earlier this year when it stopped development of its Alzheimer's disease drug, aducanumab, for a lack of efficacy. Now, Biogen says new data shows it may work after all. Can this drug pass muster with regulators? Also, Walgreen's is closing retail clinics within its stores, but that doesn't mean it's giving up on plans to offer more healthcare services entirely.

To get 50% off our Stock Advisor service, go to http://IF.Fool.com.

Direct download: 20191030_IF_Healthcare.mp3
Category:Podcast -- posted at: 4:01pm EST

Founded by Katrina Lake in 2011, StitchFix has taken the fashion world by storm. By leveraging data science, StitchFix sends customers personalized “fixes” tailored toward their size and style, and the company has continued to innovate through new initiatives like its Style Shuffle game and new Direct Buy Program. We hope you’ll enjoy this conversation between StitchFix COO Mike Smith and the Motley Fool’s Tom Gardner, Andy Cross, and Tim Beyers. 

To get 50% off our Stock Advisor service, go to http://IF.Fool.com.



Direct download: 20191029_IF_CG.mp3
Category:Podcast -- posted at: 3:30pm EST

Direct download: 20191028_IF_Financials.mp3
Category:Podcast -- posted at: 3:37pm EST

It's been a tumultuous couple of months since we did our S-1 show on co-working start up The We Company (or WeWork). Fellow IF host Nick Sciple hops on to walk through what has happened over the past couple weeks, what We's sliding valuation means for the company, investor Softbank, and its founder Adam Neumann.

Get $50 off your first job post. Linkedin.com/fool
 
Direct download: 20191025_IF_Tech.mp3
Category:Podcast -- posted at: 3:30pm EST

Tesla shocked the investing world on Wednesday night, reporting a surprise profit and positive free cash flow in its third quarter earnings report. Motley Fool Analysts Jim Mueller and Jim Gillies join the show to break down the numbers. 

Stocks Mentioned: TSLA

Thanks to Molekule for supporting our podcast.   Get 10% off your first air purifier at http://www.molekule.com with code “fool10”.

Direct download: 20191024_IF_Energy.mp3
Category:Podcast -- posted at: 3:30pm EST

2019 has been a banner year for big name IPOs, but several newly minted public companies have flow under-the-radar of most investors. 
On this episode of Industry Focus: Healthcare, host Shannon Jones talks with healthcare specialist Brian Feroldi shine a spotlight on two little-known healthcare companies that recently went public and deserve some attention: TransMedics, an organ transportation specialist, and Silk Road Medical, which has pioneered a new treatment for stroke prevention. Are either of these stocks worth buying today?
 
Stocks mentioned: TMDX, SILK.
 
Direct download: 20191023_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST

On this week’s episode of Industry Focus: Consumer Goods host Jason Moser and Fool.com contributor Asit Sharma take a closer look at Land's End and Herman Miller, two sleeper stocks with some big potential. Plus Jason and Asit highlight four companies with earnings reports coming out later this week that they'll be following. Thanks to Molekule for supporting Industry Focus.  

Stocks: LE, MLHR, TSCO, AMZN, ORLY, ELY

Get 10% off your first air purifier at http://www.molekule.com with code fool10. 

Direct download: 20191022_IF_CG.mp3
Category:Podcast -- posted at: 3:30pm EST

Earnings season is now in full swing, and most major U.S. banks have reported. In today’s Industry Focus: Financials, host Jason Moser and Fool.com contributor Matt Frankel, CFP discuss the results from 10 of the most important banks and what investors need to know. Plus, the pair discusses Schwab’s (NASDAQ: SCHW) decision to allow trading of fractional shares of stock, as well as the potential implications of the WeWork saga.

Direct download: 20191021_IF_Financials.mp3
Category:general -- posted at: 3:30pm EST

Direct download: 20191018_IF_Tech.mp3
Category:Podcast -- posted at: 3:30pm EST

With the cost of solar energy plummeting and an aging energy grid, solar is poised for rapid growth. As solar grows, so will demand for solar components, like the inverters made by Enphase and Solar Edge. On today’s episode, Motley Fool Contributor Jason Hall joins the show to break down why these components are so important and how these businesses are positioning themselves to grow.  

Listen to hear us talk a little college football and baseball playoffs!

Check out more of our content here:

Direct download: 20191017_IF_Energy.mp3
Category:Podcast -- posted at: 3:30pm EST

Pfizer's latest phase 3 trial results put its promising eczema drug on a path to challenge Regeneron and Sanofi's $2 billion-per-year drug, Dupixent. Also, how Regenxbio and Adverum Biotechnologies hope to change how a we treat a common cause of vision loss in seniors, and why United Healthcare's latest quarterly results sent shares soaring.

Check out more of our content here:

Direct download: 20191016_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST

Chanticleer Holdings, the company that owns a handful of Hooters locations along with other eateries in the burger space is being purchased by Sonnet BioTherapeutics Inc., a company that makes cancer drugs. This isn’t a combination or a plan to get researchers to wear short shorts, it’s what’s called a reverse merger. Also, Costco has opened up its own chicken farm in a bid to keep selling rotisserie chickens for $4.99.

Check out more of our content here:

Direct download: 20191015_IF_ConsumerGoods.mp3
Category:Podcast -- posted at: 3:30pm EST

More CEOs are leaving their companies in 2019 than ever before. In today’s Industry Focus: Financials, our team breaks down why we’re seeing a record number of CEO departures and whether or not it’s good for a founder to keep running maturing businesses. Plus, Fool.com and Millionacres contributor Matt Frankel, CFP gives real estate investors a bit of cautionary advise. All this, plus the stocks we’re watching now on this week’s episode.

 

Direct download: 20191014_IF_Financials.mp3
Category:Podcast -- posted at: 3:30pm EST

Facebook CEO Mark Zuckerberg recently made comments about the company's ability to defend itself from anti-trust proceedings, so we revisit Senator Elizabeth Warren's outline for how and why companies like Amazon, Facebook, and Alphabet should be broken up. Plus, we hit some more anti-competitive issues facing Apple.Stocks: FB, AAPL, AMZN, GOOG, GOOGL

Check out more of our content here:

Download their FREE guide, “Seven Key Strategies to Grow your Profits” today at NetSuite.com/fool

Direct download: 20191011_IF_Tech.mp3
Category:Podcast -- posted at: 3:30pm EST

With oil and gas production exploding in the U.S., takeaway capacity is running low, leading to oversupply and even flaring of unwanted natural gas that producers can’t get to market. That creates opportunities for midstream companies, businesses that build and operate the pipelines that take oil and gas to market. Motley Fool Contributor Matt DiLallo joins the show to share what he looks for in a midstream company and to discuss two of the biggest midstream companies, Kinder Morgan and Enterprise Products Partners. 

Stocks Mentioned: PAA, PAGP, KMI, EPD

Check out more of our content here:

Download their FREE guide, “Seven Key Strategies to Grow your Profits” today at NetSuite.com/fool



Direct download: 20191010_IF_Energy.mp3
Category:Podcast -- posted at: 3:30pm EST

Here's why post-approval setbacks have caused Puma Biotechnology, Clovis Oncology, and Regenxbio shares to tumble, and if any of these stocks are finally worth buying. Stocks: PBYI, CLVS, RGNX

Check out more of our content here:

Direct download: 20191009_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST

These days it seems like all the struggling retailers are taking their strongest performing brands and spinning them out from the larger parent companies. J Crew plans to take its Madewell brand public, and Gap intends to spin out Old Navy. Why are so many companies choosing this path and what do investors need to know about these new concepts hitting the market?Stocks: GPS, URBN

Check out more of our content here:

Direct download: 20191008_IF_ConsumerGoods.mp3
Category:Podcast -- posted at: 3:30pm EST

Over the past week, four major brokerages have decided to scrap their trading commissions. In this episode of Industry Focus: Financials, host Jason Moser and Fool.com contributor Matt Frankel, CFP discuss what it means for investors and who the big winners could be. Then, Frankel gives an overview of Crowdfunded Real Estate investing and why it’s such an exciting way to invest in properties. Plus, Frankel and Moser each give their latest stocks to watch and give an update on Facebook’s (NYSE: FB) Libra cryptocurrency project.

Check out more of our content here:

Direct download: 20191007_IF_Financials.mp3
Category:Podcast -- posted at: 3:30pm EST

We answer a listener email asking about the ins and outs of the IPO process:

- How IPOs work
- Why IPO prices can change
- And how a company like WeWork can decide to pull its IPO

Check out more of our content here:

Direct download: 20191004_IF_Tech.mp3
Category:Podcast -- posted at: 3:30pm EST

 With the rise of two-day and next-day shipping, figuring out how to get products from a warehouse to customers’ doors is becoming ever more important to business success. However, this problem is more complicated than it might seem. To solve this, more and more companies are turning to automation. Motley Fool Contributor Dan Kline joins to the show to break down what we should expect to see as technology transforms logistics. 

Stocks Mentioned: AMZN, WMT, WBA, NKE, UPS

Check out more of our content here:

Direct download: 20191003_IF_Energy.mp3
Category:Podcast -- posted at: 3:30pm EST

Why Seattle Genetics and Amgen could be the biggest winner and loser, respectively, following this year's annual European Society for Medical Oncology (ESMO) conference. Also, here's what you should know about the virtual health service Amazon's rolling out for its workers, including if it's a threat to Teladoc's future.  Stocks: SGEN, AMGN, MRTX, AMZN, TDOC

To get 50% off our Stock Advisor service, go to http://IF.Fool.com

Check out more of our content here:

Direct download: 20191002_IF_Heatlhcare.mp3
Category:Podcast -- posted at: 3:30pm EST

Michael’s is the largest craft retailer in North America, but is it a good stock? With shares down more than 40% since most recent its IPO in 2014, some may quickly dismiss the company. However, on closer inspection the company appears like it could have some value left in it. Motley Fool Contributor Asit Sharma joins the show to break down the company, and we give our thoughts on whether Michael’s is a value play or a value trap.  

Stocks Mentioned: MIK

Check out more of our content here:

Direct download: 20191001_IF_CG.mp3
Category:Podcast -- posted at: 3:30pm EST

1